- Advertisement -
- Advertisement -
BusinessEnhertu significantly delayed breast cancer progression in trial, AstraZeneca...

Enhertu significantly delayed breast cancer progression in trial, AstraZeneca says

-

- Advertisment -

AstraZeneca PLC said Monday that its Enhertu drug significantly delayed metastatic breast cancer progression in a Phase 3 trial, reinforcing the results of a prior trial.

The Anglo-Swedish pharma giant
AZN,
+2.54%
said results from the Destiny-Breast02 Phase 3 trial of Enhertu–trastuzumab deruxtecan–showed the trial met the primary endpoint, demonstrating a significant and clinically meaningful improvement in progression-free survival in patients.

Enhertu is being jointly developed and commercialized by AstraZeneca and Daiichi Sankyo Ltd.

Write to Kyle Morris at [email protected]

- Advertisement -

Latest news

Jackson Gallagher Height, Weight, Net Worth, Age, Birthday, Wikipedia, Who, Nationality, Biography

Jackson Gallagher is a renowned Entertainer, and Model from Australia. He rose to distinction for his job as Josh...

Missouri Senator Josh Hawley Calls for the Resignation of of DHS Secretary Alejandro Mayorkas for His Radical Mass Migration Agenda

Missouri Senator Josh Hawley called for the resignation of Department of Homeland Security (DHS) Secretary Alejandro Mayorkas as the...

The untold truth of French billionaire

Who is Marie Besnier Beauvalot? Wiki Bio Marie Besnier was born in Laval, Mayenne, France on 30 July 1980 –...
- Advertisement -

Nancy Pelosi is BOOED during surprise visit to New York City festival

House Speaker Nancy Pelosi was booed on stage during a surprise appearance at a New York City climate change...

Must read

- Advertisement -

You might also likeRELATED
Recommended to you

- Advertisement -